Gene expression profiling to predict recurrence of
Recommend Documents
Breast Cancer Research and Treatment. December 2014 ... Breast Cancer Res Treat (2014) 148: 599. doi:10.1007/s10549-014-3188-z ... Breast cancerRisk predictionLocoregional recurrence70-gene signatureSurgeryRadiation oncology.
higher than in patients with chemoresistant pancreatic cancers (P ¼ 0.01; 71 vs 269 days). ... agents, such as profiling of the expression of individual genes.
Jack A. Gilbert and Margaret Hughes. Abstract. Metatranscriptomics has been developed to help understand how communities respond to changes in.
Sep 20, 2016 - in snapdragon (Antirrhinum majus) [10]. ..... was verified in Arabidopsis thaliana, Astragalus membranaceus, and Tropaeolum majus [23â25].
Gene expression profiling of CHEK2 1100delC breast cancers may reveal clues to the nature of the polygenic CHEK2 model and its genes involved. Here, we ...
Furthermore, models based on the pilot data and on previously published gene sets related to ovarian cancer outcomes, did not perform significantly better than ...
dysgenesis syndrome (TDS), which includes also cryptorchidism and testicular atrophy (3). As first described by Skakkebaek, intratubular germ cell neoplasia ...
To date, these studies have identified families in which IPF is ... Vanderbilt Medical Center North .... collected data from .200 hundred families at Vanderbilt.
Oct 11, 2002 - Gene expression profiling of tumors using DNA microarrays is a promising ... Keywords: breast cancer, estrogen receptor, gene expression, ...
May 15, 2007 - 13790 ^ 5. 11. Garber ME,Troyanskaya OG, Schluens K, et al. Diver- ... don 12 and 13 mutations detection in NSCLC patients. Mol Cell Probes ...
May 8, 2009 - 15. Shintani Y, Maeda M, Chaika N, Johnson KR, Wheelock MJ: Collagen ... Frank E, Hall M, Trigg L, Holmes G, Witten IH: Data mining in bio-.
May 15, 2007 - determine if a recurrence signature also existed in lung ... prognosis in lung cancer (10â22), mostly with survival rather ... K.M. Fong is the.
May 8, 2009 - employing classification analysis (Weka) on the expression data from ..... be created, we used the classifier tool Weka, which con-.
Mar 12, 2012 - protein tyrosine phosphatase type IVA, member 1. PTP4A1. 0.03. 1.62. 1569599_at. SAM domain, SH3 domain and nuclear localization signals ...
pathological, biochemical, and quantitative RT-PCR analyses confirmed the incidence of necroinflammatory ... it is not clear what types of genes are involved or.
Nov 25, 2003 - eses: (i) NOS2 gene expression might be an element of the heart's response to .... Internal Standards (Ambion, Austin, TX) to perform multiplex.
Aug 26, 2004 - NAD-dependent formate dehydrogenase. 0.246. 1.522. SA0996. 4.37. sdhB. Succinate dehydrogenase iron-sulfur protein subunit. 0.171. 6.357.
Gene Expression Profiling of Pancreatic Cancer Reveals a. Significant Deregulation of the TGF-β Pathway and the Discovery of Genes for Prognosis. A. Klein*,1 ...
Aug 18, 2011 - Le Roch KG, Johnson JR, Ahiboh H, Chung DW, Prudhomme J, Plouffe D, ... David PH: Dynamic RNA profiling in Plasmodium falciparum ...
May 29, 2017 - In order to identify biomarkers involved in breast cancer, gene expression profiling was conducted using human breast cancer tissues.
Jul 12, 2013 - treatment entry point and a potential new clinical drug for HCC patients. ..... Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, ...
Mar 22, 2005 - E1AF (human PEA3/ETV4) is an ets family transcriptional factor. We recently reported that E1AF plays a key role in the progression of colorectal ...
Nov 10, 2014 - (HSP70), and heat shock protein 90kDa alpha (HSP90). (Table 1). ... 2, type II alpha-1a were upregulated in the muscle of crisp grass carp.
Gene expression profiling to predict recurrence of
squamous cell carcinoma of the tongue: discovery and external validation ... Supplementary Figure 4: Kaplan-Meier curves for the length of time after recurrence until cancer-specific death according to CK-4 ... Perineural invasion (%). Absent.
www.impactjournals.com/oncotarget/
Oncotarget, Supplementary Materials 2017
Gene expression profiling to predict recurrence of advanced squamous cell carcinoma of the tongue: discovery and external validation SUPPLEMENTARY MATERIALS
Supplementary Figure 1: Subgrouping through hierarchical clustering based on expression of 30 predictive genes in the discovery study.
www.impactjournals.com/oncotarget/
Oncotarget, Supplementary Materials 2017
Supplementary Figure 2: Kaplan-Meier curves of the two subgroups divided based on predictive formula in the discovery study.
www.impactjournals.com/oncotarget/
Oncotarget, Supplementary Materials 2017
Supplementary Figure 3: Receiver operating characteristic (ROC) analysis for relationship between CK-4 protein positivity and KRT4 gene expression in the discovery study.
www.impactjournals.com/oncotarget/
Oncotarget, Supplementary Materials 2017
Supplementary Figure 4: Kaplan-Meier curves for the length of time after recurrence until cancer-specific death according to CK-4 protein expression by immunohistochemical staining.
Supplementary Figure 5: Kaplan-Meier curves according to tumor differentiation in the validation study of immunohistochemical staining.
www.impactjournals.com/oncotarget/
Oncotarget, Supplementary Materials 2017
Supplementary Figure 6: Relationship of the expression of 30 genes between cluster A, cluster B and normal tissues.
Supplementary Figure 7: Prognostic index.
Oncotarget, Supplementary Materials 2017
www.impactjournals.com/oncotarget/
Supplementary Table 1: Clinicopathologic characteristics of patients in the discovery study classified according to unsupervised hierarchical clustering. See Supplementary File 1 Supplementary Table 2: Functional Enrichment Analyses in the discovery cohort. See Supplementary File 2 Supplementary Table 3: Association between potential prognostic factors and time to disease-specific death from recurrence in the validation study of immunohistochemical staining Variable
n
Age at recurrence
†
Time to disease-specific death from recurrence Hazard ratio
